As anticipated, tenofovir diphosphate levels in peripheral blood mononuclear cells at week 4 or 8 were substantially (5.3-fold) higher with TAF than with TDF.
Tenofovir exposure in plasma was much lower with TAF than TDF (area under the concentration-time curve 326.2 versus 3795.2 ng x h/mL).